Colony Group’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Colony Group’s Portfolio VRX Stock Details VRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,299	Closed	-$945K	–	995
2015 Q3	$945K	Sell	5,299 -386	-7%	-$68.8K	0.11%	176
2015 Q2	$1.26M	Buy	5,685 +122	+2%	+$27.1K	0.13%	146
2015 Q1	$1.1M	Sell	5,563 -9	-0.2%	-$1.79K	0.12%	148
2014 Q4	$797K	Buy	5,572 +801	+17%	+$115K	0.08%	199
2014 Q3	$626K	Buy	+4,771	New	+$626K	0.07%	203

Other funds holding VRX

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

SIM

Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return

Colony Group's VRX Position: Q4 2015 in Review

Colony Group sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q4 2015, closing a stake of 5,299 shares — an estimated $945K sold.

Colony Group first reported a position in VRX in Q3 2014 and held it in 5 quarters. The position peaked at $1.26M in Q2 2015. 2 funds tracked by Wall St. Rank hold VRX as of Q4 2015.

Colony Group reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q4 2015 after selling out during the quarter.
Colony Group sold 5,299 VALEANT PHARMACEUTICALS INTL shares in Q4 2015, an estimated $945K.
Colony Group first reported a position in VALEANT PHARMACEUTICALS INTL in Q3 2014 and held it in 5 quarters.
Colony Group's VALEANT PHARMACEUTICALS INTL position peaked at $1.26M in Q2 2015.
2 funds tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q4 2015.

Based on Colony Group's 13F filing for Q4 2015, filed 19 Feb 2016.